colonic neoplasm: A benign or malignant neoplasm that affects the colon. Representative examples of benign neoplasms include lipoma and leiomyoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. Colonic adenomas always exhibit epithelial dysplasia and are considered premalignant neoplasms.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3454 |
4. Check minimum number of eventsNone |
3454 |
5. Include endpointsNone |
3454 |
6. Filter based on genotype QC (FinnGen only) |
3454 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D32
- Name in latin
- Neoplasma benignum meningum cranialium
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Cerebral meninges
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Cerebral meninges
- Benign neoplasm of meninges
- Benign neoplasm of meninges
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 21809 | 16225 | 5444 |
| Only index persons | 18958 | 14404 | 4554 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.38 | 0.46 | 0.15 |
| Only index persons | 0.44 | 0.53 | 0.17 |
| Median age at first event (years) | |||
| Whole population | 64.57 | 64.55 | 64.62 |
| Only index persons | 64.01 | 63.93 | 64.27 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3454 | 2625 | 829 |
| Unadjusted period prevalence (%) | 0.77 | 0.89 | 0.37 |
| Median age at first event (years) | 62.55 | 61.48 | 65.94 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3050
- Matched controls
- 30501
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
3203.7
323.0
846
*
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
+∞
323.0
507
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
423.9
323.0
1222
48
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
+∞
323.0
1041
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
22.1
323.0
1391
1114
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
+∞
323.0
1848
*
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
265.1
323.0
393
17
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
4141.6
323.0
376
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
50.2
236.3
287
63
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
14.4
222.5
392
309
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
374.1
211.8
211
6
AA1AD
NOMESCO Finland
CT of head and brain
3.6
206.9
1257
4963
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
+∞
199.2
189
*
D32.05
ICD-10 Finland
Cerebral meninges
+∞
193.8
184
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.6
183.6
593
1251
N03AX14
ATC
levetiracetam; systemic
12.9
179.7
331
284
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
7.5
178.0
454
698
D32.03
ICD-10 Finland
Benign meningioma in ventricles
1680.3
160.8
155
*
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
+∞
141.8
135
*
H02AB02
ATC
dexamethasone; systemic
4.0
138.8
649
1951
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.3
133.5
798
2919
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
+∞
129.1
123
*
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
121.7
116
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
10.7
120.1
241
242
ZXC95
NOMESCO Finland
Use of surgical navigator
16.7
117.8
193
123
N03AF02
ATC
oxcarbazepine; oral
7.9
113.4
273
375
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
10.6
105.7
213
215
9531/0-C70.0
ICD-O-3
Meningothelial meningioma of cerebral meninges
+∞
100.6
96
*
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
32.0
99.1
132
43
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
9.3
90.9
196
223
XCK00
NOMESCO Finland
Perimetry
3.9
86.1
391
1111
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
9.4
85.6
183
205
H53.4
ICD-10 Finland
Visual field defects
8.5
82.9
189
236
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
79.8
1012
5487
9537/0-C70.0
ICD-O-3
Transitional meningioma of cerebral meninges
+∞
79.5
76
*
2152
FHL
Extraction, big brain
123.4
78.3
84
7
9539/1-C70.0
ICD-O-3
Atypical meningioma of cerebral meninges
+∞
77.4
74
*
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
40.8
75.5
95
24
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.9
66.1
195
351
R51.80
ICD-10 Finland
Headache
2.6
65.7
572
2523
N03AB02
ATC
phenytoin; systemic
11.1
64.8
126
118
WX882
NOMESCO Finland
High dependency care
6.0
64.7
186
324
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.3
61.3
198
397
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
7.3
60.7
152
219
22520
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
60.6
58
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
49.1
59.5
72
15
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.3
58.7
628
3062
9532/0-C70.0
ICD-O-3
Fibrous meningioma of cerebral meninges
+∞
58.5
56
*
D32
ICD-10 Finland
Benign neoplasm of meninges
297.5
57.4
58
*
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
5.0
57.0
191
399
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
8.7
56.1
124
147
N03AF01
ATC
carbamazepine; oral, rectal
3.5
53.2
264
796
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
50.7
748
4176
ZXC40
NOMESCO Finland
Use of ultrasound
13.5
49.5
87
66
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
17.5
48.6
77
45
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
11.3
48.0
92
84
AAK00
NOMESCO Finland
Cranioplasty
103.7
46.9
51
5
H47.2
ICD-10 Finland
Optic atrophy
22.4
46.7
68
31
XA800
NOMESCO Finland
Neuropsychological investigation
4.2
44.9
180
450
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
11.9
42.5
79
68
D33.30
ICD-10 Finland
Acoustic neuroma
12.1
42.3
78
66
N75
ICPC
Benign neoplasm nervous system
218.0
42.0
43
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.6
41.9
200
583
A02BC02
ATC
pantoprazole; systemic
1.7
41.7
2052
16636
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
11.9
41.5
77
66
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.3
41.1
425
2008
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
15.4
41.0
68
45
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.5
40.2
350
1511
WX110
NOMESCO Finland
Local anesthesy
1.7
39.8
2013
16323
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
8.7
39.5
87
103
D42.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cerebral meninges
74.5
39.0
44
6
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
22.8
38.8
56
25
N76
ICPC
Neoplasm nervous system unspecified
40.7
38.5
48
12
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
28.8
37.8
51
18
G40.10
ICD-10 Finland
Simple partial seizures
11.2
37.1
71
65
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
45.6
36.9
45
10
N02BE01
ATC
paracetamol; systemic, rectal
2.0
36.9
2662
23729
WX402
NOMESCO Finland
General anaesthesia
2.0
36.6
540
2964
ZX050
NOMESCO Finland
Stereotactic radiotherapy
11.0
36.4
70
65
R42
ICD-10 Finland
Dizziness and giddiness
1.8
35.9
758
4728
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
51.9
34.5
41
8
H02AB09
ATC
hydrocortisone; systemic
5.1
34.4
112
227
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.4
33.9
302
1316
C70.0
ICD-10 Finland
Malignant neoplasm: Cerebral meninges
93.7
33.8
37
*
D33.02
ICD-10 Finland
Another benign medial tumor of the cerebrum
121.4
33.7
36
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
10.2
33.6
67
67
R4110
NOMESCO Finland
Physiotherapy
1.7
33.3
840
5513
WF099
NOMESCO Finland
Other radiotherapy
12.5
33.2
60
49
WF002
NOMESCO Finland
Radical radiotherapy
3.2
32.7
178
573
8000/0-C70.0
ICD-O-3
Neoplasm, benign of cerebral meninges
+∞
32.3
31
*
N03AG01
ATC
valproic acid; systemic, rectal
2.8
31.9
220
828
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
36.8
31.5
40
11
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
86.0
30.8
34
*
CS494
NOMESCO Finland
Other visual field testing
4.2
30.3
120
297
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
16.8
30.2
48
29
TAB00
NOMESCO Finland
Lumbar puncture
3.0
29.1
174
599
H53.2
ICD-10 Finland
Diplopia
3.5
27.4
132
388
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
26.8
453
2588
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
6.9
26.6
67
99
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
8.1
25.6
58
73
WX872
NOMESCO Finland
Intensive care
2.7
25.0
174
660
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
8.7
25.0
54
63
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
7.9
24.9
57
73
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
39.2
24.9
31
8
S18
ICPC
Laceration/cut
1.5
23.6
1253
9715
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
11.4
23.6
44
39
AWC00
NOMESCO Finland
Reoperation of nervous system because of deep wound infection in the nervous system
126.0
23.6
25
*
H47.1
ICD-10 Finland
Papilloedema, unspecified
11.8
23.4
43
37
183
Kela drug reimbursment
Lamotrigin and topiramate
7.3
23.2
56
78
SPAT1153
SPAT
Removal of sutures
1.5
23.0
985
7275
E23.00
ICD-10 Finland
Panhypopituitarism
14.8
22.9
38
26
9530/0-C70.1
ICD-O-3
Meningioma, NOS, of spinal meninges
84.1
22.7
25
*
N03AX18
ATC
lacosamide; systemic
8.6
22.6
49
58
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
22.6
702
4798
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
7.7
22.0
51
67
9531/0-C70.9
ICD-O-3
Meningothelial meningioma of meninges, NOS
+∞
21.9
21
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
12.0
21.5
39
33
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.2
21.3
218
1013
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
20.8
472
2947
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.8
20.8
424
2566
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.0
20.7
296
1584
XX3DW
NOMESCO Finland
Time consuming IT work
1.9
20.4
327
1826
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.2
20.1
108
347
9539/1-C70.9
ICD-O-3
Atypical meningioma of meninges, NOS
+∞
19.8
19
*
9537/0-C70.9
ICD-O-3
Transitional meningioma of meninges, NOS
+∞
19.8
19
*
R90.0
ICD-10 Finland
Intracranial space-occupying lesion
24.7
19.5
27
11
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
46.3
19.2
23
5
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
8.8
18.4
39
45
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
3.4
18.1
87
258
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
15.4
17.9
29
19
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
7.1
17.8
43
61
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
9.8
17.6
35
36
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
17.3
1251
10102
G44.2
ICD-10 Finland
Tension-type headache
1.7
16.4
383
2402
L28
ICPC
Limited function/disability (L)
1.6
16.2
486
3261
N06AX11
ATC
mirtazapine; oral
1.4
16.0
901
6925
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.1
16.0
192
959
2250A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
60.3
15.8
18
*
N05CF01
ATC
zopiclone; oral
1.4
15.8
969
7564
ZXA05
NOMESCO Finland
Left side
1.5
15.6
756
5640
D33.0
ICD-10 Finland
Benign neoplasm: Brain, supratentorial
85.5
15.6
17
*
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.6
15.5
70
198
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.1
15.5
88
294
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
15.1
205
1077
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
3.1
15.1
82
268
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
14.9
217
1165
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
10.1
14.9
29
29
R53
ICD-10 Finland
Malaise and fatigue
1.5
14.8
570
4044
G50.0
ICD-10 Finland
Trigeminal neuralgia
3.5
14.8
68
196
R4150
NOMESCO Finland
Neuropsychological rehabilitation
6.7
14.8
37
56
H93.1
ICD-10 Finland
Tinnitus
2.0
14.7
197
1026
N74
ICPC
Malignant neoplasm nervous system
27.3
14.3
19
7
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
14.2
574
4113
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
14.2
1288
10690
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
13.4
14.2
24
18
G91.1
ICD-10 Finland
Obstructive hydrocephalus
9.1
14.2
29
32
R4120
NOMESCO Finland
Occupational therapy
2.0
14.1
185
959
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
5.3
14.0
42
80
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.5
13.7
470
3245
22500
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
75.5
13.6
15
*
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
75.5
13.6
15
*
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
14.8
13.6
22
15
N03AX11
ATC
topiramate; oral
3.1
13.5
74
244
2151
FHL
Resection, big brain
34.2
13.5
17
5
S06.0
ICD-10 Finland
Concussion
1.7
13.5
273
1641
N03AX16
ATC
pregabalin; oral
1.4
13.5
677
5063
R51
ICD-10 Finland
Headache
2.1
13.3
143
683
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
40.2
13.1
16
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
13.1
593
4341
DFF00
NOMESCO Finland
Pure tone audiometry
1.7
13.1
261
1562
ZXA10
NOMESCO Finland
Bilateral
1.5
13.0
541
3890
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
11.0
13.0
24
22
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
3.7
12.8
55
151
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
2.2
12.6
129
603
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
12.6
98
400
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
12.3
12.6
22
18
N01
ICPC
Headache
1.7
12.6
243
1440
N03AX12
ATC
gabapentin; oral
1.5
12.6
436
3013
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.7
12.5
272
1669
D33.37
ICD-10 Finland
Another benign tumor of the cranial nerves
130.5
12.4
13
*
P20
ICPC
Memory disturbance
1.6
12.4
358
2371
H02AB06
ATC
prednisolone; systemic
1.3
12.3
1286
10829
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
12.1
288
1812
2396A
ICD-9 Finland
Neoplasm of unspecified nature, Brain
46.8
11.9
14
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.9
11.8
175
951
G40
ICD-10 Finland
Epilepsy
5.3
11.8
35
67
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.1
11.8
45
112
H05.2
ICD-10 Finland
Exophthalmic conditions
10.5
11.7
22
21
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
30.1
11.6
15
5
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
5.4
11.6
34
64
G40.89
ICD-10 Finland
Other epilepsy
7.7
11.6
26
34
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
7.7
11.6
26
34
A28
ICPC
Limited function/disability NOS
1.5
11.5
428
3000
WX704
NOMESCO Finland
Intubation
1.8
11.5
198
1133
9532/0-C70.9
ICD-O-3
Fibrous meningioma of meninges, NOS
+∞
11.5
11
*
AAK10
NOMESCO Finland
Repair of dura
13.6
11.4
19
14
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.3
11.3
101
442
ZXC86
NOMESCO Finland
Use of endoscopic device
5.8
11.3
31
54
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.6
11.3
83
330
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
6.6
11.2
28
43
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
5.7
11.2
31
55
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
3.9
11.1
45
118
H53.1
ICD-10 Finland
Subjective visual disturbances
1.8
11.1
178
995
AA1AA
NOMESCO Finland
Head X-ray examination
4.6
11.1
37
81
TPH07
NOMESCO Finland
Cathetrisation of artery
1.6
11.0
281
1805
H46
ICD-10 Finland
Optic neuritis
5.0
10.9
34
69
2159
FHL
Other measure in this category
43.5
10.9
13
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
10.9
870
7000
N88
ICPC
Epilepsy
6.3
10.9
28
45
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
10.9
1048
8675
A02BC05
ATC
esomeprazole; systemic
1.3
10.8
1139
9541
R13
ICD-10 Finland
Dysphagia
1.8
10.8
187
1072
WX002
NOMESCO Finland
Sedation and analgesia
1.4
10.8
557
4166
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.9
10.8
162
884
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
28.1
10.7
14
5
ZXA00
NOMESCO Finland
Right side
1.3
10.7
783
6218
D33.43
ICD-10 Finland
Spinal cord
60.2
10.6
12
*
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
3.4
10.5
50
150
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.5
10.5
84
348
N03AX09
ATC
lamotrigine; oral
2.2
10.5
109
515
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
14.2
10.5
17
12
9533/0-C70.0
ICD-O-3
Psammomatous meningioma of cerebral meninges
+∞
10.4
10
*
AAE99
NOMESCO Finland
Other operation by cranial base approach
+∞
10.4
10
*
N05BA09
ATC
clobazam; oral
7.7
10.4
23
30
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.6
10.2
253
1613
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.0
10.2
135
704
G91.0
ICD-10 Finland
Communicating hydrocephalus
5.9
10.1
27
46
2040A
ICD-9 Finland
Lymphoid leukaemia, Acute
40.2
10.0
12
*
N05BA01
ATC
diazepam; systemic, rectal
1.5
9.8
366
2567
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
9.7
810
6542
UKC02
NOMESCO Finland
Cystoscopy
1.5
9.7
382
2709
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
9.6
1683
14995
R4130
NOMESCO Finland
Speech therapy
2.7
9.6
65
248
N29
ICPC
Neurological sympt/complt other
2.7
9.5
64
242
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.7
9.5
184
1093
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.5
9.4
303
2054
G47.3
ICD-10 Finland
Sleep apnoea
1.4
9.4
487
3638
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
30.1
9.4
12
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.9
9.4
37
96
20400
ICD-8 Finland
Lymphatic leukaemia, Acute
+∞
9.4
9
*
T32.0
ICD-10 Finland
Corrosions involving less than 10% of body surface
+∞
9.4
9
*
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
3.5
9.3
41
117
WX892
NOMESCO Finland
Monitored bed care
1.7
9.3
190
1147
AAF00
NOMESCO Finland
Ventriculostomy
5.0
9.2
28
56
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.5
9.1
69
281
D33.3
ICD-10 Finland
Benign neoplasm: Cranial nerves
15.6
9.0
14
9
SPAT1053
SPAT
Memory test
1.4
9.0
431
3173
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
36.8
9.0
11
*
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
10.0
9.0
17
17
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
10.0
9.0
17
17
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
7.0
9.0
21
30
N06AX26
ATC
vortioxetine; oral
1.9
9.0
122
646
CE2W4
NOMESCO Finland
Eye movement mapping
9.5
8.8
17
18
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
2.4
8.7
70
295
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
50.1
8.7
10
*
G35
ICD-10 Finland
Multiple sclerosis
3.2
8.6
44
141
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.5
8.6
279
1898
K90
ICPC
Stroke/cerebrovascular accident
2.3
8.6
78
349
C08CA01
ATC
amlodipine; oral
1.3
8.6
985
8285
XKD00
NOMESCO Finland
Uroflowmetry
1.5
8.6
303
2098
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.6
8.5
36
100
H54.4
ICD-10 Finland
Blindness, monocular
6.4
8.5
21
33
AWW99
NOMESCO Finland
Other reoperation in surgery of the nervous system
20.1
8.5
12
6
G51.0
ICD-10 Finland
Bell palsy
2.3
8.4
77
345
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.6
8.4
216
1389
AA6AD
NOMESCO Finland
Cranial bones CT examination
90.3
8.4
9
*
AAK99
NOMESCO Finland
Other operation on skull or dura
90.3
8.4
9
*
XF400
NOMESCO Finland
ECG with 12 standard connections
1.4
8.4
413
3054
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
12.8
8.4
14
11
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
2.8
8.3
51
186
N80
ICPC
Head injury other
2.8
8.3
51
186
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.0
8.3
106
548
J01DB01
ATC
cefalexin; oral
1.3
8.2
2268
21152
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.2
8.1
82
384
K91
ICPC
Cerebrovascular disease
3.0
8.1
44
148
D42.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Meninges, unspecified
33.4
8.1
10
*
102
Kela drug reimbursment
Diabetes insipidus
8.1
8.1
17
21
N17
ICPC
Vertigo/dizziness
1.5
8.0
306
2153
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.7
8.0
160
962
N28
ICPC
Limited function/disability (N)
2.9
8.0
47
166
K07.60
ICD-10 Finland
Snapping jaw
1.9
8.0
120
659
A02BC03
ATC
lansoprazole; oral
1.3
8.0
820
6785
R20.2
ICD-10 Finland
Paraesthesia of skin
1.7
8.0
166
1008
UJF32
NOMESCO Finland
Coloscopy
1.3
8.0
694
5614
N06AX16
ATC
venlafaxine; oral
1.5
7.9
323
2301
N07CA01
ATC
betahistine; oral
1.6
7.9
209
1354
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.7
7.9
32
86
R11
ICD-10 Finland
Nausea and vomiting
1.6
7.9
210
1365
H50.2
ICD-10 Finland
Vertical strabismus
4.1
7.8
28
68
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
7.0
7.8
18
26
H03AA01
ATC
levothyroxine sodium; systemic
1.3
7.7
697
5666
E22.1
ICD-10 Finland
Hyperprolactinaemia
5.0
7.7
23
46
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.8
7.7
138
804
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
7.4
7.7
17
23
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
7.7
1006
8574
A02BA02
ATC
ranitidine; systemic
1.3
7.7
548
4306
N18
ICPC
Paralysis/weakness
2.5
7.6
57
232
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.3
7.6
896
7538
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
25.1
7.6
10
*
AA1CF
NOMESCO Finland
Extensive MRI examination of brain with median intensity magnet
25.1
7.6
10
*
R55
ICD-10 Finland
Syncope and collapse
1.5
7.6
274
1911
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
8.9
7.5
15
17
N99
ICPC
Neurological disease other
3.0
7.5
41
139
A02BC01
ATC
omeprazole; systemic
1.3
7.5
755
6223
SPAT1043
SPAT
Audiometry
1.5
7.4
278
1948
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.5
7.3
292
2074
SPAT1216
SPAT
Assessment of functional ability
1.4
7.3
426
3241
N06AB10
ATC
escitalopram; oral
1.4
7.3
456
3509
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.5
7.3
256
1775
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.5
7.2
251
1737
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
3.5
7.2
31
89
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.8
7.1
107
588
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
6.6
7.1
17
26
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
5.0
7.1
21
42
WX725
NOMESCO Finland
Noninvasive ventilation
1.8
7.1
118
672
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
3.2
7.1
34
106
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
7.1
687
5630
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
6.9
248
1723
M03BX01
ATC
baclofen; systemic
2.6
6.9
49
194
9101
FHL
Bone biopsy
10.9
6.8
12
11
N03AX15
ATC
zonisamide; oral
10.9
6.8
12
11
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
9.3
6.8
13
14
UDC00
NOMESCO Finland
Ear microscopy
1.6
6.8
178
1154
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
4.5
6.8
22
49
D35.30
ICD-10 Finland
Craniopharyngoma
40.1
6.8
8
*
D43.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system
40.1
6.8
8
*
R5140
NOMESCO Finland
Monitoring the use of the aid
1.5
6.7
234
1615
KMAK
NOMESCO Finland
NA
1.2
6.7
1269
11220
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.5
6.7
238
1651
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
3.5
6.7
29
84
Q85.1
ICD-10 Finland
Tuberous sclerosis
22.6
6.7
9
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
6.7
286
2064
G93.0
ICD-10 Finland
Cerebral cysts
4.9
6.7
20
41
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
12.3
6.6
11
9
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
12.3
6.6
11
9
SPAT1301
SPAT
No procedures
1.2
6.5
832
7041
WF003
NOMESCO Finland
Adjuvant radiotherapy
1.8
6.5
106
601
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
10.0
6.5
12
12
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
6.5
372
2822
2180A
ICD-9 Finland
Uterine leiomyoma, Submucous leiomyoma of uterus
1.5
6.5
186
1232
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
6.5
795
6695
C71.09
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles other or unspecified histology
70.0
6.4
7
*
D33.4
ICD-10 Finland
Benign neoplasm: Spinal cord
70.0
6.4
7
*
D33.01
ICD-10 Finland
Medial ganglion glioma of the cerebrum
70.0
6.4
7
*
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.9
6.4
91
492
109
Kela drug reimbursment
Multiple sclerosis
3.3
6.3
29
88
E23.05
ICD-10 Finland
Lack of TSH
8.2
6.3
13
16
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
5.2
6.3
18
35
ZZF00
NOMESCO Finland
Graft of adipose tissue
3.2
6.3
30
94
G50.1
ICD-10 Finland
Atypical facial pain
2.3
6.3
52
226
D33
ICD-10 Finland
Benign neoplasm of brain and other parts of central nervous system
+∞
6.3
6
*
D33.15
ICD-10 Finland
Another benign tumor of the cerebellum
+∞
6.3
6
*
D33.06
ICD-10 Finland
Plexus papilloma of the ventricle of the brain
+∞
6.3
6
*
D33.46
ICD-10 Finland
Benign neurofibroma in the nerve root of the spinal cord
+∞
6.3
6
*
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
26.7
6.2
8
*
AA1AM
NOMESCO Finland
Short MRI examination of brain with 3 Tesla magnet
7.0
6.2
14
20
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.2
6.2
761
6408
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
2.1
6.2
64
307
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
6.2
902
7743
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
5.0
6.2
18
36
E23.2
ICD-10 Finland
Diabetes insipidus
6.3
6.2
15
24
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.2
6.1
1184
10463
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.6
6.1
149
948
N03AX23
ATC
brivaracetam; systemic
12.5
6.1
10
8
AA4DG
NOMESCO Finland
Very extensive MRI examination of sella turcica with high intensity magnet
12.5
6.1
10
8
S09.9
ICD-10 Finland
Unspecified injury of head
2.8
6.1
36
130
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.8
6.1
104
602
XCK10
NOMESCO Finland
Photography of fundus of eye
1.4
6.0
253
1818
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
10.0
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
383
159
26.97
307.65
1.6
1.8
—
—
—
0
0
891
3409
3.17
173.52
5.6
6.9
1.0
1.2
mmol/l
0.59
646
2652
542
1517
4.05
170.93
4.9
8.6
24.0
24.4
mmol/l
1.88
528
1411
890
3431
3.15
170.80
5.6
6.8
4.9
5.1
kpa
6.07
859
3267
889
3430
3.14
170.31
5.6
6.8
16.4
12.3
kpa
53.06
858
3264
2259
15791
2.24
107.21
7.6
6.4
1.2
1.2
mmol/l
5.58
1966
13261
2088
14329
2.16
101.22
6.5
5.7
1.2
1.2
mmol/l
7.93
1921
12881
2410
17558
2.23
99.36
5.6
4.5
6.6
6.7
mmol/l
1.30
2322
16449
101
95
10.92
93.53
2.3
2.2
52.2
51.8
umol/l
0.03
83
72
162
272
6.20
92.63
1.8
1.4
—
—
—
0
0
880
4540
2.26
85.98
2.1
2.0
28.9
29.7
s
3.28
850
4399
237
608
4.11
82.47
1.6
1.3
72.5
23.3
e6/l
1.04
182
458
237
610
4.10
82.10
1.7
1.4
1576.9
1230.4
e6/l
0.22
186
489
104
133
8.03
76.30
1.9
1.5
—
—
—
0
0
1456
9396
1.95
75.90
2.3
2.1
149.1
187.3
u/l
2.21
1383
8760
1222
7602
1.94
69.54
3.8
3.7
94.0
90.8
%
4.68
1184
7394
236
690
3.60
67.94
1.3
1.2
705.6
527.3
mg/l
2.81
223
650
217
609
3.74
66.36
1.3
1.2
3.6
3.8
mmol/l
0.85
194
569
562
2742
2.25
60.71
2.8
2.1
372.6
371.1
nmol/l
0.05
522
2492
566
2820
2.20
57.87
7.2
7.6
121.3
119.5
g/l
1.65
550
2710
409
1866
2.35
51.25
7.0
8.1
0.7
0.7
%
1.27
409
1854
408
1880
2.33
49.91
7.1
7.9
1.2
1.3
%
2.22
408
1868
408
1884
2.32
49.65
7.1
8.1
95.5
94.0
%
9.50
408
1874
1846
13925
1.70
49.57
3.9
4.0
—
—
—
0
0
1116
7364
1.76
48.63
2.3
2.3
—
—
—
0
0
189
598
3.29
47.90
2.6
1.6
423.0
309.3
mu/l
2.65
181
539
94
197
4.88
42.14
1.3
1.3
2.5
2.1
mmol/l
1.02
80
183
55
85
6.56
34.06
2.6
1.9
0.7
1.3
ug/l
1.36
55
78
603
3729
1.75
30.98
6.3
6.3
104.7
104.3
mmol/l
1.55
593
3655
356
1900
1.97
29.17
9.0
6.9
25.0
24.6
mmol/l
1.30
342
1757
55
105
5.31
27.47
3.2
2.6
29.2
29.2
umol/l
0.02
47
75
2337
20040
1.51
27.23
5.6
4.9
763.0
2151.3
e6/l
1.49
30
265
203
917
2.29
25.63
5.4
3.7
3.8
3.8
mmol/l
2.23
198
868
2629
23265
1.54
25.13
4.9
4.3
14.9
14.9
pmol/l
0.39
2401
21006
3131
28969
1.86
24.91
18.9
15.0
21.3
23.5
mg/l
3.82
2732
23085
423
2511
1.78
24.67
5.7
6.8
8.1
10.0
mmol/l
6.24
397
2394
3226
30204
2.03
23.85
22.6
17.4
139.6
139.7
mmol/l
0.28
3181
29445
2529
22289
1.50
23.75
4.6
4.3
12.8
13.4
mm/h
1.10
2351
20487
2978
27244
1.68
23.60
5.9
5.2
3.2
2.1
mu/l
0.62
2736
24763
3230
30277
2.03
23.44
22.6
17.5
3.9
4.0
mmol/l
2.66
3181
29475
1903
15935
1.43
23.01
5.9
6.2
10.5
11.1
umol/l
1.18
1792
15068
107
378
2.89
22.47
3.6
5.2
348.4
363.6
umol/l
0.63
102
329
217
1076
2.08
21.69
5.1
3.5
1.2
1.4
mmol/l
1.64
217
1056
2615
23370
1.49
21.44
8.1
7.6
78.1
79.1
u/l
0.55
2460
21859
823
5943
1.51
21.41
4.0
3.8
152.8
302.8
ng/l
1.80
627
4741
706
4948
1.54
21.11
2.7
3.1
0.8
0.8
mmol/l
3.02
654
4572
1441
11667
1.40
20.03
4.1
3.7
38.3
90.6
ng/l
0.74
1039
8208
1149
8952
1.42
19.85
3.5
3.2
51.5
75.6
e6/l
0.89
907
6815
1774
14903
1.39
19.68
5.9
5.8
1.9
1.9
e9/l
0.24
1552
13004
1995
17137
1.39
19.08
9.2
9.1
4.1
4.1
e9/l
0.47
1757
14923
1791
15116
1.38
19.06
6.1
5.9
0.2
0.2
e9/l
2.00
1563
13155
112
442
2.59
19.05
1.6
1.3
12.3
14.3
u/l
0.66
89
348
1621
13489
1.38
18.65
4.8
4.6
35.1
35.2
g/l
0.35
1499
12462
1636
13637
1.38
18.61
6.1
5.9
2.7
2.8
%
1.76
1521
12615
1071
8320
1.42
18.52
3.4
3.1
0.4
0.5
e6/l
0.37
839
6263
198
1013
2.01
18.17
2.1
2.2
501.5
691.1
ug/l
0.30
182
949
1308
10540
1.39
18.16
4.1
3.7
73.3
119.7
e6/l
2.33
967
7389
818
6078
1.45
17.96
1.8
1.8
1108.1
1183.9
nmol/l
1.53
601
4530
693
4989
1.49
17.88
1.8
1.8
—
—
—
0
0
1670
14026
1.37
17.83
6.2
6.1
27.7
27.7
%
0.06
1550
12949
1564
13036
1.37
17.35
2.1
2.0
97.9
96.4
pmol/l
0.52
765
6340
1643
13823
1.36
17.06
6.0
5.8
57.6
57.4
%
0.35
1532
12820
558
3880
1.52
16.94
5.3
5.2
1.0
1.0
mmol/l
1.07
503
3568
273
1590
1.78
16.81
8.4
9.7
—
—
—
0
0
223
1257
1.83
15.30
6.0
5.6
1.5
1.6
%
1.01
207
1174
309
1918
1.67
15.10
3.1
3.2
4.3
4.4
pmol/l
2.07
277
1679
3220
30667
1.74
14.84
21.8
17.7
74.3
75.1
umol/l
0.77
3220
30659
388
2592
1.56
14.00
6.3
6.2
1.5
1.3
mmol/l
1.24
378
2505
2058
18206
1.32
13.87
3.5
3.1
47.6
48.6
u/l
0.21
1898
16722
49
146
3.39
13.82
1.0
1.1
—
—
—
0
0
81
323
2.54
13.58
1.8
1.4
284.0
275.8
mosm/kgh2o
2.31
67
245
191
1066
1.84
13.55
1.5
1.3
31.7
35.1
iu/l
0.74
169
917
67
245
2.77
13.33
1.1
1.1
—
—
—
0
0
22
35
6.32
13.27
2.0
1.2
—
—
—
0
0
55
181
3.07
13.21
1.2
1.1
10.2
13.9
nmol/l
0.13
13
37
1547
13256
1.30
12.69
2.5
2.3
77.9
79.8
nmol/l
1.74
1361
11770
213
1258
1.74
12.50
6.1
5.6
0.9
0.9
%
1.13
198
1176
185
1050
1.81
12.44
2.6
2.2
11.0
12.1
nmol/l
0.99
153
910
72
286
2.55
12.21
1.1
1.1
—
5.0
—
0
6
49
160
3.09
11.96
1.1
1.1
1.0
1.1
u/l
0.77
28
85
626
4744
1.39
11.70
3.0
2.9
4.1
3.3
e6/l
0.93
354
2543
310
2050
1.56
11.66
2.2
2.4
17.5
25.7
au/ml
0.69
11
97
55
195
2.85
11.63
1.2
1.1
53.1
38.0
mg/l
0.77
49
165
43
135
3.21
11.22
1.3
1.3
36.5
72.0
%
—
10
15
798
6326
1.34
11.14
2.8
2.6
6.4
6.2
e6/l
0.13
720
5498
51
180
2.86
10.90
1.1
1.1
—
—
—
0
0
2912
27447
1.39
10.83
17.0
14.1
78.7
77.2
ml/min/173m2
3.85
2578
22689
52
187
2.81
10.74
1.1
1.1
313.5
253.1
mg/l
0.74
46
162
282
1861
1.56
10.70
1.2
1.3
40.9
45.9
au/ml
—
8
86
266
1734
1.58
10.64
1.4
1.5
—
—
—
0
0
663
5150
1.36
10.52
2.8
2.7
1.0
1.3
e6/l
1.42
391
2936
126
672
1.91
10.36
8.0
8.1
107.4
105.0
mmol/l
6.80
111
600
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
45
153
2.97
10.29
1.0
1.1
—
—
—
0
0
470
3485
1.40
9.88
1.7
1.7
—
—
—
0
0
280
1885
1.53
9.71
1.7
1.6
—
—
—
0
0
514
3888
1.38
9.58
8.0
7.3
—
—
—
0
0
2871
27146
1.34
9.27
6.3
6.0
39.6
40.0
mmol/mol
1.26
2644
24863
1283
11039
1.26
9.22
3.6
3.4
2.4
2.4
mmol/l
0.09
1087
9506
465
3481
1.39
9.21
1.7
1.8
—
—
—
0
0
1106
9359
1.27
9.13
3.1
3.2
31.2
33.8
u/l
0.78
1035
8858
19
38
5.02
9.09
1.3
1.2
47.3
53.4
%
0.19
12
17
1418
12369
1.25
8.95
3.0
2.8
125.0
121.9
ug/l
0.18
1285
11323
1635
14536
1.24
8.53
6.0
5.4
0.0
0.0
estimate
0.80
326
2663
1628
14469
1.24
8.51
4.3
4.0
0.0
0.0
estimate
0.00
318
2658
359
2606
1.42
8.49
3.9
3.4
89.7
87.0
ng/l
0.25
305
2199
183
1158
1.61
8.33
1.8
1.8
—
—
—
0
0
386
2848
1.40
8.31
2.5
2.3
30.3
37.2
u/l
3.42
335
2426
1649
14711
1.23
8.21
4.4
4.1
0.0
0.0
estimate
1.32
316
2652
20
46
4.37
8.14
2.6
3.2
44.0
40.6
umol/l
0.24
20
35
3184
30736
1.46
8.08
12.4
11.0
25.0
24.6
u/l
0.59
3085
29543
139
829
1.71
7.97
1.7
1.6
—
—
—
0
0
1456
12859
1.23
7.86
10.4
9.7
0.0
0.0
e9/l
0.46
1182
10451
1119
9610
1.24
7.86
2.5
2.5
62.0
57.5
u/l
0.46
1011
8804
447
3409
1.36
7.85
2.3
2.6
7.8
8.0
umol/l
0.06
372
2956
2986
28561
1.34
7.65
5.2
4.8
5.9
5.9
mmol/l
2.28
2704
25807
130
774
1.71
7.52
1.5
1.4
17.3
20.1
iu/ml
—
5
20
790
6568
1.26
7.29
1.9
1.7
1.5
1.2
mg/l
0.51
608
5024
190
1254
1.55
7.26
2.1
1.9
—
—
—
0
0
1065
9162
1.23
7.23
2.9
3.0
1470.2
1416.8
ng/l
0.15
913
7865
294
2134
1.41
6.96
3.1
2.7
9.8
10.5
g/l
2.13
267
1940
3260
31711
1.50
6.93
28.5
22.3
254.5
254.4
e9/l
0.03
3205
30852
3261
31730
1.50
6.84
28.6
22.5
132.0
132.7
g/l
2.19
3230
31229
184
1225
1.53
6.78
1.8
1.8
36.7
39.4
u/l
1.21
157
1091
3260
31724
1.49
6.77
28.5
22.3
4.4
4.4
e12/l
0.25
3198
30756
3260
31726
1.49
6.74
28.5
22.4
6.9
6.7
e9/l
4.30
3199
30756
10
14
7.16
6.70
1.3
1.4
—
—
—
0
0
906
7737
1.23
6.47
2.3
2.3
2.9
3.0
mg/l
0.84
760
6566
26
85
3.07
6.46
1.0
1.2
—
—
—
0
0
871
7448
1.23
6.08
1.6
1.5
20.3
21.2
nmol/l
0.93
749
6264
2688
25575
1.23
5.86
20.8
16.4
38.7
38.9
%
0.44
1816
17302
122
765
1.62
5.86
2.9
2.4
3.4
3.6
g/l
0.48
116
724
307
2312
1.36
5.84
1.7
1.6
—
—
—
0
0
802
6827
1.23
5.82
1.7
1.7
11350129.0
29167110.9
pmol/l
0.76
652
5592
11
20
5.51
5.80
1.4
1.4
22.0
43.2
%
0.82
11
13
119
744
1.62
5.79
2.7
2.3
181.8
194.9
%
0.98
114
708
25
87
2.89
5.61
1.3
1.2
18.4
13.6
%
0.17
12
11
1774
16293
1.18
5.55
2.8
2.7
—
—
—
0
0
3030
29276
1.28
5.44
5.4
5.2
2.8
2.8
mmol/l
0.25
2767
26656
726
6159
1.23
5.40
3.2
3.1
2.5
2.5
mmol/l
0.37
617
5400
340
2638
1.32
5.30
2.4
2.4
6.7
6.4
ug/l
0.11
277
2277
31
126
2.47
5.20
2.2
2.7
866.2
1196.2
u/ml
0.50
31
126
56
292
1.93
5.11
2.8
2.8
—
—
—
0
0
10
19
5.28
5.04
1.4
1.4
21.8
14.2
%
—
10
13
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
146
990
1.50
5.02
3.3
2.9
0.3
0.4
u/ml
0.17
83
580
2482
23550
1.19
5.00
23.2
18.4
13.8
13.8
%
0.25
2434
23018
57
305
1.88
4.83
1.4
1.4
0.3
0.3
nmol/l
0.04
41
217
346
2727
1.30
4.82
2.4
2.9
163.9
196.6
ng/l
1.30
314
2485
396
3180
1.28
4.77
3.7
3.5
—
—
—
0
0
2964
28643
1.25
4.77
4.9
4.6
4.7
4.7
mmol/l
0.29
2716
26216
66
372
1.79
4.75
1.5
1.3
261.8
279.9
pmol/l
0.19
56
285
2941
28401
1.24
4.74
4.8
4.6
1.5
1.5
mmol/l
4.01
2674
25820
413
3337
1.27
4.74
4.2
4.1
242.1
249.5
u/l
0.26
385
3130
868
7578
1.19
4.73
2.7
2.6
3288.5
5579.9
umol/l
1.14
732
6468
240
1806
1.35
4.63
3.7
3.6
5.2
5.2
kpa
0.30
212
1671
926
8144
1.19
4.62
1.6
1.6
1.4
1.3
mmol/l
0.89
800
6789
141
969
1.47
4.56
2.0
1.6
275.0
258.6
titre
—
8
43
330
2609
1.29
4.50
2.4
2.7
65.2
66.3
g/l
2.22
296
2360
91
571
1.61
4.45
2.0
2.9
28.1
33.5
umol/l
2.58
73
487
55
300
1.85
4.43
1.8
1.5
—
—
—
0
0
338
2704
1.28
4.21
3.9
3.5
1.6
2.0
mmol/l
1.21
282
2226
226
1713
1.34
4.18
3.7
3.6
2.0
2.0
mmol/l
0.04
159
1300
21
79
2.67
4.15
1.0
1.1
—
—
—
0
0
21
79
2.67
4.15
1.0
1.1
—
—
—
0
0
112
758
1.49
3.96
1.8
1.8
4.0
4.9
iu/l
0.37
37
258
614
5285
1.20
3.85
1.3
1.3
34.6
35.8
iu/ml
0.07
182
1684
9
15
6.01
3.81
1.2
1.2
2.7
1.0
%
—
9
9
2835
27405
1.19
3.81
4.3
4.1
1.3
1.3
mmol/l
0.51
2553
24685
97
645
1.52
3.75
1.5
1.3
—
—
—
0
0
97
645
1.52
3.75
1.5
1.3
—
—
—
0
0
161
1180
1.38
3.72
1.2
1.2
0.2
1.5
u/ml
2.34
13
109
1209
11014
1.15
3.70
4.8
4.3
—
—
—
0
0
32
155
2.07
3.66
2.3
2.5
—
—
—
0
0
335
2726
1.25
3.64
3.9
3.4
5.7
5.8
kpa
1.10
329
2656
474
4007
1.21
3.60
2.9
2.5
21.2
22.1
%
0.55
418
3357
10
26
3.85
3.52
1.0
1.0
—
—
—
0
0
51
294
1.75
3.50
6.0
4.6
10.0
49.6
u/ml
3.97
14
81
109
754
1.46
3.50
1.9
2.0
12.3
11.6
mg/l
0.13
99
693
324
2646
1.25
3.43
4.4
3.7
1.2
1.2
mmol/l
0.54
285
2288
49
282
1.75
3.39
1.9
1.5
—
—
—
0
0
504
4318
1.20
3.32
2.7
2.4
2.3
2.3
g/l
0.48
462
3972
124
888
1.41
3.32
1.5
1.6
1.2
1.2
g/l
0.55
115
845
25
115
2.18
3.28
1.2
1.1
—
—
—
0
0
120
859
1.41
3.23
1.5
1.6
0.2
0.2
g/l
0.59
110
817
278
2248
1.26
3.22
3.8
2.9
4.8
4.5
kpa
0.88
269
2183
868
7790
1.15
3.20
4.9
4.5
0.0
0.0
estimate
1.28
315
2610
137
1005
1.38
3.20
3.7
3.3
30.6
115.5
mg/l
0.91
112
839
78
514
1.53
3.19
2.0
1.5
—
—
—
0
0
8
15
5.34
3.19
1.0
1.1
—
—
—
0
0
12
39
3.08
3.09
1.0
1.2
—
—
—
0
0
18
74
2.44
3.04
1.1
1.1
0.7
0.7
umol/24h
0.02
11
38
471
4043
1.19
3.04
24.5
25.5
1.4
1.3
inr
0.12
66
565
136
1007
1.36
3.02
3.8
3.3
28.8
57.1
mg/l
1.40
111
841
19
81
2.35
2.98
1.2
1.1
189.5
281.5
pmol/l
1.06
11
58
15
57
2.64
2.96
1.1
1.1
—
—
—
0
0
132
977
1.37
2.94
3.8
3.3
1.1
1.5
ratio
—
6
85
61
390
1.57
2.88
1.2
1.2
5.1
4.0
u/ml
0.13
14
114
113
819
1.39
2.87
1.2
1.3
—
—
—
0
0
12
41
2.93
2.85
1.1
1.0
—
—
—
0
0
12
41
2.93
2.85
1.0
1.2
—
—
—
0
0
14
53
2.65
2.79
1.4
1.3
109.6
84.5
ng/l
0.53
14
53
290
2399
1.23
2.76
3.1
2.7
62.5
63.8
ml/min/173m2
0.20
108
1002
89
624
1.44
2.73
2.7
2.5
15.4
16.0
%
0.65
44
314
97
693
1.41
2.69
1.8
1.5
—
—
—
0
0
96
686
1.41
2.67
1.4
1.2
—
—
—
0
0
151
1160
1.32
2.66
2.2
2.0
2.6
1.9
ug/l
0.31
118
1011
17
73
2.34
2.65
1.0
1.1
—
—
—
0
0
10
32
3.13
2.64
1.0
1.2
—
—
—
0
0
534
4687
1.16
2.64
2.8
2.4
12.5
12.7
umol/l
0.19
499
4306
37
213
1.75
2.63
1.2
1.1
110.0
153.0
titre
—
5
37
18
80
2.26
2.60
1.0
1.1
—
—
—
0
0
88
623
1.42
2.58
2.8
2.9
8.5
8.0
kpa
0.48
81
574
11
38
2.90
2.58
1.0
1.1
—
—
—
0
0
11
38
2.90
2.58
1.1
1.2
1.5
1.7
umol/24h
0.37
11
38
87
615
1.43
2.58
1.2
1.2
23.3
45.2
u/ml
—
9
73
145
1114
1.31
2.56
4.3
3.9
25.0
25.0
mmol/l
0.06
130
1017
569
5032
1.16
2.55
1.3
1.3
7.0
12.9
u/ml
1.72
208
1880
12
44
2.73
2.54
1.1
1.1
—
—
—
0
0
18
81
2.23
2.53
1.0
1.1
—
—
—
0
0
59
387
1.53
2.53
1.3
1.2
3.0
4.9
u/ml
0.92
21
150
450
3915
1.17
2.50
4.9
4.7
32.9
33.3
%
0.37
312
2550
47
296
1.60
2.41
3.6
3.3
64.1
57.6
%
1.27
37
191
12
46
2.61
2.35
1.2
1.1
—
—
—
0
0
12
46
2.61
2.35
1.1
1.0
—
—
—
0
0
93
678
1.38
2.34
1.9
1.5
—
—
—
0
0
9
28
3.22
2.30
1.0
1.1
—
—
—
0
0
50
327
1.54
2.21
1.7
1.6
—
—
—
0
0
16
73
2.20
2.21
1.0
1.1
—
—
—
0
0
92
679
1.36
2.17
2.1
2.2
125.6
127.2
g/l
0.27
61
478
15
67
2.24
2.17
3.9
2.0
—
—
—
0
0
43
273
1.58
2.17
1.1
1.1
—
—
—
0
0
111
844
1.33
2.16
1.2
1.3
33.3
39.7
u/ml
—
9
52
64
444
1.45
2.15
2.0
1.8
3873.6
2474.3
u/l
0.19
23
170
59
403
1.47
2.14
1.7
1.5
—
—
—
0
0
16
74
2.17
2.14
1.3
1.1
—
—
—
0
0
25
137
1.83
2.13
2.0
1.6
6.5
5.6
nmol/l
0.08
20
113
13
55
2.37
2.12
1.3
1.3
—
—
—
0
0
57
389
1.47
2.09
1.1
1.1
—
—
—
0
0
124
965
1.30
2.06
1.4
1.3
—
—
—
0
0
84
618
1.37
2.04
1.6
1.6
—
—
—
0
0
8
26
3.08
2.01
1.0
1.1
—
—
—
0
0
14
63
2.23
2.00
1.1
1.2
—
—
—
0
0
696
6346
1.12
1.96
4.8
4.6
1.0
1.0
kg/l
0.22
127
977
48
321
1.50
1.95
1.7
1.4
30.5
36.2
u/l
0.54
43
262
96
728
1.33
1.93
2.7
3.1
24.9
25.2
mmol/l
0.25
83
632
11
45
2.45
1.93
1.3
1.5
—
—
—
0
0
110
851
1.30
1.93
1.5
1.6
0.1
6.7
iu/ml
0.50
27
183
62
438
1.42
1.92
1.4
1.4
—
—
—
0
0
23
129
1.79
1.85
1.3
1.2
—
—
—
0
0
27
159
1.70
1.85
1.1
1.1
1.0
1.0
ratio
—
8
55
165
1349
1.23
1.85
3.8
3.7
24.0
24.2
mmol/l
0.45
156
1217
112
876
1.29
1.82
1.6
1.7
—
—
—
0
0
57
403
1.42
1.78
2.2
2.4
256.0
1164.1
u/ml
—
5
27
15
74
2.03
1.75
1.1
1.1
89.5
88.9
%
—
8
36
27
163
1.66
1.71
3.2
2.1
837.6
686.6
e6/l
0.45
15
66
30
187
1.61
1.69
1.7
1.4
0.8
1.1
promille
0.46
21
142
471
4235
1.13
1.68
1.4
1.4
—
—
—
0
0
154
1268
1.22
1.64
2.0
2.4
3.5
3.7
g/l
2.43
109
901
15
76
1.98
1.64
1.1
1.2
—
—
—
0
0
22
127
1.74
1.64
1.0
1.2
—
—
—
0
0
154
1269
1.22
1.63
2.0
2.4
—
—
—
0
0
62
453
1.38
1.63
1.2
1.2
—
—
—
0
0
10
43
2.33
1.60
1.7
1.9
—
—
—
0
0
43
295
1.46
1.60
2.9
3.9
—
—
—
0
0
67
498
1.35
1.59
3.9
3.4
2.0
1.3
%
0.50
55
387
145
1192
1.23
1.58
2.0
2.5
3.1
3.1
g/l
0.21
109
922
33
215
1.54
1.56
1.2
1.1
—
—
—
0
0
33
216
1.53
1.54
1.2
1.1
—
—
—
0
0
33
216
1.53
1.54
1.2
1.1
—
—
—
0
0
33
216
1.53
1.54
1.2
1.1
—
—
—
0
0
33
216
1.53
1.54
1.2
1.1
—
—
—
0
0
68
510
1.34
1.53
4.6
4.8
161.1
614.5
iu/ml
—
10
75
153
1270
1.21
1.53
2.0
2.4
7.3
7.5
g/l
0.76
113
943
18
100
1.80
1.53
1.5
1.5
2.4
3.6
umol/l
1.43
18
90
37
249
1.49
1.52
2.2
1.4
—
—
—
0
0
37
249
1.49
1.52
2.2
1.4
—
—
—
0
0
37
249
1.49
1.52
2.2
1.4
—
—
—
0
0
36
242
1.49
1.49
1.6
1.5
—
—
—
0
0
12
59
2.04
1.43
2.3
2.9
—
—
—
0
0
81
632
1.29
1.41
1.6
1.5
—
—
—
0
0
681
6312
1.10
1.41
1.3
1.3
0.8
1.6
u/ml
4.68
160
1630
32
213
1.51
1.40
1.0
1.0
805.8
723.1
ng/l
0.34
19
134
379
3407
1.13
1.39
2.5
2.4
1.8
1.8
%
0.11
341
3009
115
939
1.23
1.37
1.4
1.4
299.5
280.3
ug/g
0.43
63
542
162
1370
1.19
1.36
2.9
2.5
0.6
0.7
%
0.31
156
1312
5
17
2.94
1.36
1.0
1.0
—
—
—
0
0
15
82
1.83
1.35
1.1
1.4
115.6
123.6
nmol/l
—
7
58
32
215
1.49
1.35
1.0
1.0
33.9
46.2
ng/l
1.16
21
135
14
75
1.87
1.34
1.1
1.3
96.0
88.3
%
—
8
38
329
2941
1.13
1.33
2.1
2.1
0.2
0.2
g/l
1.06
299
2744
38
267
1.43
1.30
1.1
1.2
—
—
—
0
0
5
18
2.78
1.28
1.0
5.6
—
—
—
0
0
5
18
2.78
1.28
1.0
1.1
—
—
—
0
0
334
3000
1.13
1.26
3.3
3.1
0.9
0.8
ug/l
0.59
245
2070
140
1179
1.20
1.25
2.1
2.5
9.4
10.2
g/l
1.54
117
987
16
92
1.74
1.25
2.1
1.5
0.5
0.4
ug/l
0.16
11
53
50
372
1.35
1.24
2.0
1.5
63.4
59.3
%
0.36
35
238
17
101
1.69
1.19
1.1
1.1
1499.1
1725.0
miu/ml
0.28
17
101
33
230
1.44
1.19
1.2
1.1
—
—
u/ml
—
0
0
10
50
2.00
1.16
1.0
1.1
—
—
—
0
0
54
412
1.32
1.15
1.4
1.3
110.4
121.5
u/ml
—
9
87
68
536
1.27
1.14
1.7
2.0
0.8
0.8
nmol/l
0.20
61
441
112
935
1.20
1.12
1.6
1.8
—
—
—
0
0
562
5223
1.09
1.11
5.8
5.2
2.6
3.3
ug/l
1.02
501
4609
374
3411
1.11
1.10
1.9
2.0
115.5
132.1
ug/g
0.55
281
2642
55
424
1.30
1.10
1.2
1.2
318.8
298.0
u/ml
0.21
32
243
12
66
1.82
1.09
1.2
1.3
—
—
—
0
0
30
211
1.43
1.06
1.0
1.0
333.9
331.2
ng/l
0.01
21
134
95
787
1.21
1.05
1.2
1.3
15.1
8.3
u/ml
0.31
17
143
36
263
1.37
1.03
1.4
1.4
—
—
—
0
0
16
252
0.63
1.03
1.3
1.5
—
—
—
0
0
53
411
1.29
1.03
2.4
2.2
39.3
26.2
mg/l
0.67
15
105
7
34
2.06
1.02
2.0
2.9
0.3
0.8
u/field
—
7
34
127
1088
1.17
0.98
2.2
2.5
0.6
0.9
g/l
1.02
112
937
452
4189
1.09
0.97
4.9
4.5
22.4
21.6
%
0.62
242
2106
93
776
1.20
0.97
1.2
1.3
2.1
6.4
u/ml
—
10
82
27
190
1.42
0.96
1.7
1.4
—
—
—
0
0
104
878
1.19
0.96
2.1
2.4
0.0
0.0
g/l
0.00
96
814
74
604
1.23
0.96
1.3
1.3
192.5
213.1
miu/ml
0.18
32
270
14
85
1.65
0.94
1.3
1.2
—
—
—
0
0
117
1001
1.17
0.93
2.0
2.3
37.0
37.4
g/l
0.33
101
849
6
27
2.22
0.93
1.0
1.1
—
—
—
0
0
112
956
1.18
0.92
2.0
2.4
0.0
0.0
g/l
1.36
103
874
12
70
1.72
0.92
1.1
1.2
—
—
—
0
0
6
28
2.14
0.91
1.8
2.4
—
—
—
0
0
30
218
1.38
0.91
1.9
2.2
655.7
628.3
ml
0.15
18
144
105
893
1.18
0.91
2.1
2.4
0.0
0.0
g/l
0.00
96
816
78
646
1.21
0.90
1.8
1.6
—
—
—
0
0
219
1966
1.12
0.89
1.2
1.2
172.4
147.2
iu/ml
0.40
74
739
6
30
2.00
0.87
1.5
1.3
—
—
—
0
0
16
239
0.67
0.84
1.3
1.4
—
—
—
0
0
16
239
0.67
0.84
1.3
1.4
—
—
—
0
0
82
689
1.19
0.83
2.9
3.1
1.6
1.6
mg/l
0.07
77
632
16
238
0.67
0.83
1.3
1.4
—
—
—
0
0
16
238
0.67
0.83
1.3
1.4
—
—
—
0
0
21
146
1.44
0.82
2.7
1.4
—
—
—
0
0
21
146
1.44
0.82
2.7
1.4
—
—
—
0
0
21
146
1.44
0.82
2.7
1.4
—
—
—
0
0
21
146
1.44
0.82
2.7
1.4
—
—
—
0
0
28
376
0.74
0.82
1.4
1.4
1644.7
2251.7
e6/l
0.44
22
279
6
32
1.88
0.81
34.8
14.2
4.5
5.1
mmol/l
—
6
32
173
1936
0.89
0.81
1.8
1.7
—
—
—
0
0
50
400
1.25
0.81
1.8
1.4
—
—
—
0
0
6
33
1.82
0.79
1.0
1.1
—
—
—
0
0
52
420
1.24
0.78
1.7
1.4
—
—
—
0
0
116
1010
1.15
0.78
2.9
2.8
—
—
—
0
0
86
731
1.18
0.78
1.5
1.3
—
—
—
0
0
30
225
1.34
0.78
1.1
1.1
—
—
—
0
0
23
165
1.40
0.77
1.8
1.5
—
—
—
0
0
290
2668
1.09
0.77
1.6
1.7
1.4
1.5
%
0.14
245
2306
378
3520
1.08
0.76
3.6
3.9
15.1
23.4
ug/l
0.37
303
2838
23
166
1.39
0.75
1.8
1.5
—
—
—
0
0
5
24
2.08
0.74
1.0
1.4
—
—
—
0
0
5
24
2.08
0.74
1.2
1.2
—
—
—
0
0
52
423
1.23
0.74
1.7
1.4
—
—
—
0
0
13
196
0.66
0.73
1.4
1.5
—
—
—
0
0
7
38
1.84
0.73
2.0
2.0
20.0
20.1
umol/l
—
7
38
93
801
1.17
0.73
1.8
1.4
—
—
—
0
0
46
371
1.24
0.71
1.1
1.3
40.9
46.9
u/ml
—
5
25
17
117
1.46
0.71
3.1
1.5
—
—
—
0
0
17
117
1.46
0.71
3.1
1.5
—
—
—
0
0
16
109
1.47
0.70
1.6
2.4
227.3
166.1
umol/l
—
7
60
16
109
1.47
0.70
2.9
1.8
16.5
88.7
ug/l
0.50
16
98
51
417
1.23
0.70
1.7
1.4
—
—
—
0
0
17
118
1.44
0.69
3.1
1.5
—
—
—
0
0
961
9258
1.05
0.69
3.1
3.1
6.8
6.8
mmol/l
0.00
804
7685
52
428
1.22
0.68
1.7
1.4
—
—
—
0
0
51
420
1.22
0.67
1.7
1.4
—
—
—
0
0
13
86
1.51
0.66
1.2
1.2
—
—
—
0
0
104
914
1.14
0.65
1.3
1.2
—
—
—
0
0
45
369
1.22
0.62
2.1
2.0
4633.9
1075.5
u/ml
0.36
45
361
976
9438
1.05
0.60
3.8
3.9
7.3
8.2
mg/mmol
0.24
591
5638
19
139
1.37
0.60
1.3
1.3
—
—
—
0
0
159
1443
1.11
0.60
1.1
1.0
—
—
—
0
0
50
417
1.20
0.60
1.7
1.4
—
—
—
0
0
34
272
1.25
0.59
1.7
1.5
22.1
33.0
%
1.13
23
171
7
114
0.61
0.58
10.1
12.9
1049.1
835.1
nmol/l
—
7
108
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
6
35
1.72
0.57
2.7
1.6
—
—
—
0
0
84
736
1.14
0.57
1.4
1.5
—
—
—
0
0
81
708
1.15
0.57
1.4
1.3
—
—
—
0
0
215
1987
1.09
0.56
3.0
3.8
32.4
66.0
u/ml
2.51
206
1914
25
194
1.29
0.55
1.2
1.2
—
—
—
0
0
10
65
1.54
0.55
1.2
1.3
—
—
—
0
0
102
908
1.13
0.55
1.3
1.2
—
—
—
0
0
33
266
1.24
0.55
1.9
2.2
1.5
2.1
u/field
0.52
14
101
128
1157
1.11
0.54
3.1
3.3
3122.0
3809.1
u/ml
0.08
104
969
6
39
1.54
0.53
1.0
1.4
—
—
—
0
0
28
223
1.26
0.52
1.9
1.6
—
—
—
0
0
78
686
1.14
0.51
1.2
1.1
—
—
—
0
0
21
161
1.31
0.51
1.7
1.9
0.9
3.2
u/field
1.28
14
115
39
324
1.21
0.50
1.2
1.3
7.5
7.5
mmol/l
0.00
31
231
35
423
0.83
0.50
1.4
1.5
—
—
—
0
0
49
417
1.18
0.50
1.4
1.6
—
—
—
0
0
26
207
1.26
0.49
1.7
1.3
—
—
—
0
0
18
136
1.33
0.49
1.1
1.1
—
9.1
u/ml
—
0
18
7
45
1.56
0.49
1.1
1.5
117.7
108.7
%
—
7
45
27
334
0.81
0.48
1.4
1.4
6106.3
81461.0
e6/l
2.28
18
195
68
774
0.88
0.48
1.6
1.8
—
—
—
0
0
184
1704
1.08
0.48
1.3
1.2
181.9
175.5
u/ml
0.04
168
1555
148
1359
1.09
0.47
1.8
1.7
1.5
1.6
g/l
0.20
128
1161
19
146
1.30
0.47
1.3
1.2
178.8
284.6
u/l
0.61
14
133
45
383
1.18
0.46
1.6
1.4
—
—
—
0
0
148
1362
1.09
0.46
1.3
1.3
—
—
—
0
0
58
505
1.15
0.46
1.7
1.4
—
—
—
0
0
51
440
1.16
0.45
1.6
1.4
—
—
—
0
0
28
228
1.23
0.45
1.0
1.0
—
—
—
0
0
7
50
1.40
0.45
1.0
1.1
—
—
—
0
0
5
31
1.61
0.43
1.0
1.2
—
—
—
0
0
26
212
1.23
0.42
1.7
1.3
—
—
—
0
0
10
70
1.43
0.41
1.0
1.1
—
—
—
0
0
5
33
1.52
0.41
1.2
1.0
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
23.3
—
0
8
44
381
1.16
0.39
1.1
1.1
0.7
1.4
u/ml
0.63
15
147
19
151
1.26
0.38
1.0
1.1
—
—
—
0
0
99
1082
0.91
0.38
1.4
1.3
—
—
—
0
0
79
715
1.11
0.37
3.7
3.2
0.8
0.8
nmol/l
0.60
58
549
36
417
0.86
0.36
1.1
1.1
13.9
1453.1
iu/ml
—
8
89
18
144
1.25
0.35
1.1
1.1
—
—
—
0
0
14
109
1.29
0.33
1.0
1.0
—
—
—
0
0
505
5214
0.96
0.33
1.4
1.4
—
—
—
0
0
23
274
0.84
0.32
1.3
1.5
—
—
—
0
0
61
675
0.90
0.32
3.1
3.1
570.2
821.4
u/ml
0.15
53
614
21
174
1.21
0.31
1.3
1.2
—
—
—
0
0
7
55
1.27
0.30
1.9
1.5
—
—
—
0
0
23
194
1.19
0.29
1.7
1.6
—
—
—
0
0
33
288
1.15
0.29
1.2
1.2
—
—
—
0
0
13
162
0.80
0.28
1.5
1.7
—
—
—
0
0
21
177
1.19
0.27
1.3
1.2
—
—
—
0
0
8
64
1.25
0.27
1.1
1.0
—
—
—
0
0
65
599
1.09
0.24
3.0
3.5
56.3
57.8
%
0.43
65
599
19
161
1.18
0.24
1.0
1.0
—
—
—
0
0
89
832
1.07
0.24
1.9
1.7
—
—
—
0
0
23
199
1.16
0.23
1.6
1.5
0.9
1.0
g/l
0.17
23
199
26
228
1.14
0.22
1.3
1.2
—
—
—
0
0
7
93
0.75
0.22
1.4
1.6
9.7
8.7
ug/l
—
7
93
17
144
1.18
0.22
3.5
2.9
—
—
—
0
0
43
391
1.10
0.22
1.1
1.1
—
—
—
0
0
5
42
1.19
0.21
1.8
2.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
2.4
—
3.1
—
0
12
0
12
0.00
0.21
0.0
3.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
2.4
—
0
14
18
155
1.16
0.19
1.1
1.1
—
—
—
0
0
29
322
0.90
0.18
1.0
1.1
—
—
—
0
0
46
424
1.09
0.18
1.2
1.1
—
—
—
0
0
7
59
1.19
0.18
1.0
1.3
—
—
—
0
0
144
1388
1.04
0.15
1.7
1.7
—
—
—
0
0
18
203
0.89
0.15
1.2
1.2
88.5
77.6
u/l
0.36
13
179
23
255
0.90
0.15
2.2
1.5
32.2
21.5
u/ml
—
5
49
11
129
0.85
0.14
1.5
1.4
—
—
—
0
0
63
666
0.94
0.14
2.2
2.4
71.1
99.4
ug/min
0.33
27
392
9
107
0.84
0.13
2.2
1.3
—
—
—
0
0
79
760
1.04
0.10
1.0
1.1
2.6
6.7
u/ml
—
7
75
89
922
0.96
0.10
1.5
1.5
—
—
—
0
0
13
146
0.89
0.10
1.0
1.1
—
—
—
0
0
17
187
0.91
0.10
1.1
1.3
9.6
11.7
mmol/l
—
5
54
17
154
1.10
0.10
1.1
1.4
—
—
—
0
0
17
154
1.10
0.10
1.1
1.4
—
—
—
0
0
161
1573
1.02
0.09
1.8
1.8
—
—
—
0
0
6
54
1.11
0.09
1.0
1.5
—
—
—
0
0
40
380
1.05
0.09
1.1
1.1
—
—
—
0
0
53
552
0.96
0.08
1.3
1.3
—
—
—
0
0
62
643
0.96
0.08
3.1
3.9
31.7
27.1
mg/l
0.27
30
389
6
74
0.81
0.07
2.5
1.7
-0.0
1.2
mmol/l
—
6
68
34
323
1.05
0.07
1.4
1.7
—
—
—
0
0
8
76
1.05
0.07
1.1
2.8
—
—
—
0
0
8
76
1.05
0.07
1.1
2.8
—
—
—
0
0
21
196
1.07
0.07
1.8
2.0
—
—
—
0
0
8
90
0.89
0.06
1.4
1.7
—
—
—
0
0
16
173
0.92
0.06
1.2
1.1
36.6
23.2
u/l
0.46
11
124
28
293
0.96
0.05
1.8
1.4
22091.2
95701.9
e6/l
1.07
18
193
91
896
1.02
0.03
1.8
1.7
3.5
3.6
mg/l
0.03
71
656
21
201
1.05
0.03
1.9
1.9
16.8
13.6
%
—
8
80
21
218
0.96
0.02
1.4
1.5
2.3
6.8
u/l
—
9
104
34
348
0.98
0.01
1.2
1.2
61.9
57.0
u/l
0.22
22
243
36
352
1.02
0.01
1.0
1.0
3.9
3.5
u/ml
0.07
16
140
14
147
0.95
0.01
3.0
4.3
—
—
—
0
0
16
154
1.04
0.00
1.7
1.3
—
—
—
0
0
16
154
1.04
0.00
1.7
1.3
—
—
—
0
0
26
258
1.01
0.00
4.2
2.0
—
—
—
0
0
14
141
0.99
0.00
1.4
1.2
—
—
—
0
0
14
141
0.99
0.00
1.1
1.1
—
—
—
0
0
46
459
1.00
0.00
1.1
1.2
29.5
37.3
u/l
0.31
40
388
74
743
1.00
0.00
2.1
1.6
8956.0
11423.5
e6/l
0.58
60
538
6
61
0.98
0.00
1.0
1.0
—
—
—
0
0
8
84
0.95
0.00
1.1
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
9
97
0.93
0.00
3.2
1.7
—
—
—
0
0
9
98
0.92
0.00
1.7
1.8
—
—
—
0
0
5
55
0.91
0.00
1.2
1.7
—
—
—
0
0
5
51
0.98
0.00
1.6
2.8
15.5
14.6
ml/dl
—
5
45
0
9
0.00
0.00
0.0
5.0
—
377.8
—
0
9
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_MENINGES_CEREBRAL and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MENINGES_CEREBRAL | 1.557 [1.41, 1.72] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.127 |
During the follow-up period (1.1.1998 — 31.12.2019), 2938 out of 11921 females with CD2_BENIGN_MENINGES_CEREBRAL died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MENINGES_CEREBRAL | 1.748 [1.52, 2.01] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 1266 out of 3849 males with CD2_BENIGN_MENINGES_CEREBRAL died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_MENINGES_CEREBRAL.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.156% | 0.314% |
| 5 | 0.846% | 2.025% |
| 10 | 2.121% | 4.629% |
| 15 | 4.094% | 8.658% |
| 20 | 7.325% | 14.584% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MENINGES_CEREBRAL – Benign neoplasm: Cerebral meninges
GWS hits: 9
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data